Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia

Completed · Phase 1 · Has a placebo group

Conditions studied: Hyperinsulinemic Hypoglycemia

In brief

The purpose of the study is to evaluate the effectiveness of exenatide in adults experiencing episodes of hyperinsulinemic hypoglycemia following Roux-en-Y bariatric surgery.

Key facts

Study ID
NCT02685852
Run by
University of Minnesota
People needed
11
Starts
2016-02-01
Expected to finish
2019-07-22
Last updated by the study team
2021-05-06

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.